8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001867096-26-000091 Size: 170 KB Item 8.01: Other Events
Directly affected
- XERS Xeris Biopharma Holdings
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001867096-26-000091 Size: 170 KB Item 8.01: Other Events
Source: sec-edgar
Xeris Biopharma Holdings (XERS) since this story, compared with the market
Since the first closing price after “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” Xeris Biopharma Holdings (XERS) is +8.84%. The S&P 500 fund (SPY) is -0.67% over the same days, a +9.51% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
| Xeris Biopharma Holdings (XERS) | that day | -3.98% | final price |
| Xeris Biopharma Holdings (XERS) | the next day | -0.98% | final price |
| Xeris Biopharma Holdings (XERS) | two days later | +1.47% | final price |
| Xeris Biopharma Holdings (XERS) | three days later | +7.66% | final price |
| Xeris Biopharma Holdings (XERS) | three days earlier | +2.90% | final price |
| Xeris Biopharma Holdings (XERS) | five days earlier | -0.49% | final price |
Who is named in “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)”
Companies carried with this story
- XERS Xeris Biopharma Holdings
Xeris Biopharma Holdings (XERS) is linked, with no stored direction, high confidence in the 14 Oct 2026 story “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> XERS
How “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)” reaches Xeris Biopharma Holdings (XERS)
Xeris Biopharma Holdings (XERS) is the company in “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” the 14 Oct 2026 this story story.
Xeris Biopharma Holdings (XERS) is on the page because SEC 8-K filing -> direct issuer disclosure -> XERS
Dates and price levels for Xeris Biopharma Holdings (XERS)
XERS traded between 7.41 and 11.41 across 17 sessions. The latest close on file is 10.96.
A simple score for Xeris Biopharma Holdings (XERS)
11 out of 100
“8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)” scores 11 out of 100. The score uses 1 sources, a -0.18% difference versus the S&P 500 (SPY), and 1 linked companies.